HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR), makers of Ampyra® (dalfampridine), today announced the launch of Ampyra Dialogues, the first-ever online talk show where patients and medical experts talk about how walking problems affect people living with MS. The first edition of Ampyra Dialogues debuts on World MS Day, Wednesday, May 30, 2012 on www.AmpyraJourneys.com.
